Please assess the completion status of the following clinical trial:

Trial Title: Clinical Value of FEC-PET Combined With Endorectal MRI for Pre-therapeutic Staging of Prostate Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically diagnosed prostate cancer (needle biopsy)~* Radical prostatectomy as primary treatment~* No nutrition within 12 hours before Positron-Emission-Tomography (PET)~* No food containing choline within 24 hous before PET~* Age \> 50 years~Exclusion Criteria:~* Total endo-prothesis of the hip region~* Clinical or chemical detection of an acute infection~* Missing patient agreement~* Secondary cancer~* Surgical treatment within 3 month before PET~* Claustrophobia~* Medical drugs with choline~* Severe liver damage~* Cardiac infarction~* Bradycardia (pulse rate \< 55/min)~* Allergic reaction against Neurotropan~* Bronchial asthma~* Cardiac pacemaker~* Small metal implants (e.g., clips, cochlea-implants, etc.)

- Gender: MALE
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Patients with prostate carcinoma confirmed by needle biopsy, age \>50 years, planned radical prostatectomy with lymph-node dissection, fasting for \>12 hours before FEC-PET and an interval between biopsy and PET \>3 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).